International Journal of Molecular Sciences (Aug 2020)

Tracking Antimicrobial Resistance Determinants in Diarrheal Pathogens: A Cross-Institutional Pilot Study

  • Chris R. Taitt,
  • Tomasz A. Leski,
  • Michael G. Prouty,
  • Gavin W. Ford,
  • Vireak Heang,
  • Brent L. House,
  • Samuel Y. Levin,
  • Jennifer A. Curry,
  • Adel Mansour,
  • Hanan El Mohammady,
  • Momtaz Wasfy,
  • Drake Hamilton Tilley,
  • Michael J. Gregory,
  • Matthew R. Kasper,
  • James Regeimbal,
  • Paul Rios,
  • Guillermo Pimentel,
  • Brook A. Danboise,
  • Christine E. Hulseberg,
  • Elizabeth A. Odundo,
  • Abigael N. Ombogo,
  • Erick K. Cheruiyot,
  • Cliff O. Philip,
  • Gary J. Vora

DOI
https://doi.org/10.3390/ijms21165928
Journal volume & issue
Vol. 21, no. 16
p. 5928

Abstract

Read online

Infectious diarrhea affects over four billion individuals annually and causes over a million deaths each year. Though not typically prescribed for treatment of uncomplicated diarrheal disease, antimicrobials serve as a critical part of the armamentarium used to treat severe or persistent cases. Due to widespread over- and misuse of antimicrobials, there has been an alarming increase in global resistance, for which a standardized methodology for geographic surveillance would be highly beneficial. To demonstrate that a standardized methodology could be used to provide molecular surveillance of antimicrobial resistance (AMR) genes, we initiated a pilot study to test 130 diarrheal pathogens (Campylobacter spp., Escherichia coli, Salmonella, and Shigella spp.) from the USA, Peru, Egypt, Cambodia, and Kenya for the presence/absence of over 200 AMR determinants. We detected a total of 55 different determinants conferring resistance to ten different categories of antimicrobials: genes detected in ≥ 25 samples included blaTEM, tet(A), tet(B), mac(A), mac(B), aadA1/A2, strA, strB, sul1, sul2, qacEΔ1, cmr, and dfrA1. The number of determinants per strain ranged from none (several Campylobacter spp. strains) to sixteen, with isolates from Egypt harboring a wider variety and greater number of genes per isolate than other sites. Two samples harbored carbapenemase genes, blaOXA-48 or blaNDM. Genes conferring resistance to azithromycin (ere(A), mph(A)/mph(K), erm(B)), a first-line therapeutic for severe diarrhea, were detected in over 10% of all Enterobacteriaceae tested: these included >25% of the Enterobacteriaceae from Egypt and Kenya. Forty-six percent of the Egyptian Enterobacteriaceae harbored genes encoding CTX-M-1 or CTX-M-9 families of extended-spectrum β-lactamases. Overall, the data provide cross-comparable resistome information to establish regional trends in support of international surveillance activities and potentially guide geospatially informed medical care.

Keywords